Aquestive Therapeutics Forecast Revenue Growth Analysts estimate an earnings decrease this quarter of $ per share, a decrease next quarter of $ per. It currently has a Growth Score of D. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a. AQST's current price target is $ Learn why top analysts are making this stock forecast for Aquestive Therapeutics at MarketBeat. The analyst firm set a price target for $ expecting AQST to rise to within 12 months (a possible % upside). 22 analyst firms have reported ratings in. Track Aquestive Therapeutics Inc (AQST) Stock Price, Quote, latest community messages, chart, news and other stock related information.
AQST - Aquestive Therapeutics, Inc. (NasdaqGM) - Share Price and News. Aquestive Therapeutics, Inc. NasdaqGM. The latest Aquestive Therapeutics stock prices, stock quotes, news, and AQST history to help you invest and trade smarter. View Aquestive Therapeutics, Inc. AQST stock quote prices, financial information, real-time forecasts, and company news from CNN. Aquestive Therapeutics Inc (AQST Stock Forecast) price prediction is USD. The price forecast is kobag.onlineber 14, Sunday; and USD for. A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. What is the Aquestive Therapeutics stock forecast? · Aquestive Therapeutics stock prediction for 1 year from now: $ (%) · Aquestive Therapeutics. future price: according to them, AQST price has a max estimate of USD and a min estimate of USD. Watch AQST chart and read a more detailed Aquestive. Aquestive Therapeutics, Inc. Stock ; Mean consensus. BUY ; Number of Analysts. 8 ; Last Close Price. USD ; Average target price. USD ; Spread / Average. At this time, the relative strength index (RSI) of Aquestive Therapeutics' share price is approaching This suggests that the stock is in nutural. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock. WARREN, N.J., March 19, (GLOBE NEWSWIRE) -- Aquestive.
Stock Price Forecast. The 7 analysts with month price forecasts for AQST stock have an average target of , with a low estimate of and a high. The forecasts for Aquestive Therapeutics, Inc. (AQST) range from a low of $7 to a high of $ The average price target represents a increase of $ from. On average, Wall Street analysts predict that Aquestive Therapeutics's share price could reach $ by Aug 14, The average Aquestive Therapeutics stock. Aquestive Therapeutics Stock Forecast, AQST stock price prediction. Price target in 14 days: USD. The best long-term & short-term Aquestive. The average price target is $ with a high estimate of $13 and a low estimate of $7. Sign in to your SmartPortfolio to see more analyst recommendations. AQST appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this happens when there is a positive sentiment following the. Aquestive Therapeutics (AQST) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. According to analysts, AQST price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ AQST will report FY earnings on 03/11/ Yearly Estimates.
Wall Street analysts forecast AQST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AQST is. AQST | Complete Aquestive Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. AQST Stock Overview · Trading at % below our estimate of its fair value · Revenue is forecast to grow % per year · Negative shareholders equity · Currently. Analyst Price Targets ; Apr '24, US$ US$ +% ; Mar '24, US$ US$ +% ; Feb '24, US$ US$ +% ; Jan '24, US$ US$ +. AQST - Aquestive Therapeutics - Stock Forecast AQST is currently covered by 6 analysts with an average price target of $ This is a potential upside of.
Aquestive Therapeutics Inc Stock Price Forecast, "AQST" Predictons for Analyst. Target Price. · 8 analysts ; Earnings. EPS Forecast. Down. Next quarter ; Investor. New Investor. Armistice Capital Llc.